16 Analysts Have This To Say About Elevance Health
16 Analysts Have This To Say About Elevance Health
16位分析师对Elevance Health发表看法
Elevance Health (NYSE:ELV) has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有16位分析师对Elevance Health（纽约证券交易所代码：ELV）进行了分析，揭示了从看涨到看跌的不同观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $605.69, a high estimate of $649.00, and a low estimate of $557.00. Surpassing the previous average price target of $590.17, the current average has increased by 2.63%.
分析师12个月目标股价的见解已经公布，平均目标股价为605.69美元，最高估计为649.00美元，低估值为557.00美元。超过了之前的平均目标股价590.17美元，目前的平均价格上涨了2.63％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级：详细审查
The standing of Elevance Health among financial experts becomes...
通过对分析师近期行...
登录免费看全文
登录/注册